NextCure Ownership 2024 | Who Owns NextCure Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

57.38%

Insider Ownership

8.85%

Retail Ownership

33.77%

Institutional Holders

49.00

NextCure Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SOFINNOVA INVESTMENTS, INC.9.58%0.22%2,671,856--4,248,251Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP8.96%0.32%2,500,000575,00029.87%3,975,000Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC6.05%0.31%1,687,955328,91824.20%2,683,848Jun 30, 2024
ORBIMED ADVISORS LLC4.09%0.04%1,141,200--1,814,508Jun 30, 2024
VANGUARD GROUP INC3.54%-987,324--1,569,845Jun 30, 2024
BLACKROCK INC.2.73%-761,180-154-0.02%1,210,277Jun 30, 2024
CABLE CAR CAPITAL LLC2.21%1.03%615,878--979,246Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.16%0.10%602,994458,474317.24%958,760Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC1.99%0.03%556,105--884,207Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.75%0.00%488,440--774,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.66%0.00%462,14461,74415.42%734,809Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.64%0.00%458,340-675,738-59.58%728,761Jun 30, 2024
FEDERATED HERMES, INC.1.17%0.00%327,405--520,574,000Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.16%0.28%323,3421,6850.52%514,114Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.99%0.31%276,465-30,000-9.79%439,579Jun 30, 2024
CARDIFF PARK ADVISORS, LLC0.94%0.04%262,000--416,580Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.73%0.00%203,800--324,042Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.70%-195,92921,22212.15%311,614Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.0.66%0.00%184,486-242,231-56.77%293,333Jun 30, 2024
MACQUARIE GROUP LTD0.54%0.00%150,000--239,000Jun 30, 2024

NextCure's largest institutional shareholder is SOFINNOVA INVESTMENTS, INC., holding 9.58% of the company's total share outstanding, currently valued at $4.25M. The top 10 institutional shareholders own together 43.05% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CABLE CAR CAPITAL LLC2.21%1.03%615,878--979,246Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP8.96%0.32%2,500,000575,00029.87%3,975,000Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.99%0.31%276,465-30,000-9.79%439,579Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC6.05%0.31%1,687,955328,91824.20%2,683,848Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.16%0.28%323,3421,6850.52%514,114Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.9.58%0.22%2,671,856--4,248,251Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.16%0.10%602,994458,474317.24%958,760Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC0.47%0.06%130,000--206,700Jun 30, 2024
CARDIFF PARK ADVISORS, LLC0.94%0.04%262,000--416,580Jun 30, 2024
ORBIMED ADVISORS LLC4.09%0.04%1,141,200--1,814,508Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC1.99%0.03%556,105--884,207Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.32%0.03%89,01446,000106.94%141,532Jun 30, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.21%0.02%58,259--92,632Jun 30, 2024
HARBOURVEST PARTNERS LLC0.04%0.01%10,044--15,970Jun 30, 2024
XTX TOPCO LTD0.07%0.00%20,8741,1946.07%33,190Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.25%0.00%70,600--112,254Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.75%0.00%488,440--774,000Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.73%0.00%203,800--324,042Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.66%0.00%462,14461,74415.42%734,809Jun 30, 2024
FEDERATED HERMES, INC.1.17%0.00%327,405--520,574,000Jun 30, 2024

The largest NextCure shareholder by % of total assets is CABLE CAR CAPITAL LLC. The company owns 615.88K shares of NextCure (NXTC), representing 1.03% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LOGOS GLOBAL MANAGEMENT LP8.96%0.32%2,500,000575,00029.87%3,975,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC2.16%0.10%602,994458,474317.24%958,760Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC6.05%0.31%1,687,955328,91824.20%2,683,848Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC1.66%0.00%462,14461,74415.42%734,809Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.32%0.03%89,01446,000106.94%141,532Jun 30, 2024
ARMISTICE CAPITAL, LLC0.13%0.00%36,00036,000100.00%57,240Jun 30, 2024
WALLEYE CAPITAL LLC0.08%0.00%21,24721,247100.00%33,783Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.70%-195,92921,22212.15%311,614Jun 30, 2024
NORTHERN TRUST CORP0.17%-47,56213,81640.94%75,624,000Jun 30, 2024
STATE STREET CORP0.23%-65,3928,30014.54%103,973,000Jun 30, 2024
LPL FINANCIAL LLC0.11%-30,0003,00011.11%47,700Jun 30, 2024
BANK OF AMERICA CORP /DE/0.02%-5,3692,64396.96%8,536Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.16%0.28%323,3421,6850.52%514,114Jun 30, 2024
XTX TOPCO LTD0.07%0.00%20,8741,1946.07%33,190Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.31%-86,5597060.82%137,629Jun 30, 2024
ROYAL BANK OF CANADA0.00%-403403100.00%1,000Jun 30, 2024
JPMORGAN CHASE & CO0.00%-80630.37%1,282Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-48--76Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.00%-385--612Jun 30, 2024
RHUMBLINE ADVISERS0.00%-703--1,117Jun 30, 2024

As of Jun 30 2024, NextCure's largest institutional buyer is LOGOS GLOBAL MANAGEMENT LP. The company purchased 575.00K stocks of NXTC, valued at $3.98M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC1.64%0.00%458,340-675,738-59.58%728,761Jun 30, 2024
MORGAN STANLEY--1-402,257-100.00%2Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.10%0.00%27,600-365,640-92.98%43,884Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.0.66%0.00%184,486-242,231-56.77%293,333Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.99%0.31%276,465-30,000-9.79%439,579Jun 30, 2024
WELLS FARGO & COMPANY/MN----2,157-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.00%-1,227-1,047-46.04%1,951Jun 30, 2024
UBS GROUP AG0.04%-9,928-885-8.18%15,785Jun 30, 2024
BLACKROCK INC.2.73%-761,180-154-0.02%1,210,277Jun 30, 2024
BARCLAYS PLC0.24%-67,518-30-0.04%107,000Jun 30, 2024
CABLE CAR CAPITAL LLC2.21%1.03%615,878--979,246Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.9.58%0.22%2,671,856--4,248,251Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC0.47%0.06%130,000--206,700Jun 30, 2024
CARDIFF PARK ADVISORS, LLC0.94%0.04%262,000--416,580Jun 30, 2024
ORBIMED ADVISORS LLC4.09%0.04%1,141,200--1,814,508Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC1.99%0.03%556,105--884,207Jun 30, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.21%0.02%58,259--92,632Jun 30, 2024
HARBOURVEST PARTNERS LLC0.04%0.01%10,044--15,970Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.25%0.00%70,600--112,254Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.75%0.00%488,440--774,000Jun 30, 2024

As of Jun 30 2024, NextCure's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -0.68M shares of NXTC, valued at $728.76K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC0.13%0.00%36,00036,000100.00%57,240Jun 30, 2024
WALLEYE CAPITAL LLC0.08%0.00%21,24721,247100.00%33,783Jun 30, 2024
ROYAL BANK OF CANADA0.00%-403403100.00%1,000Jun 30, 2024

NextCure's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 36.00K shares, valued at $57.24K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----2,157-100.00%-Jun 30, 2024

NextCure's largest sold out institutional shareholder by shares sold is WELLS FARGO & COMPANY/MN, sold -2.16K shares, valued at -, as of undefined.

NextCure Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Voya VARIABLE PRODUCTS TRUST0.22%79,822--Mar 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.20%188,891--Jan 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.15%306,855--Feb 29, 2024
DELAWARE GROUP EQUITY FUNDS IV0.13%150,000--Mar 28, 2024
Federated Hermes MDT Series0.13%315,180--Jan 31, 2024
360 Funds0.12%25,000--Feb 29, 2024
MERIDIAN FUND INC0.10%222,984--Mar 28, 2024
Voya EQUITY TRUST0.09%126,419--Feb 29, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.08%14,673--Mar 28, 2024
NEXPOINT FUNDS I0.06%217,139--Dec 31, 2023
BlackRock Health Sciences Trust0.04%10,934--Mar 31, 2024
PUTNAM GLOBAL HEALTH CARE FUND0.03%54,348--Feb 29, 2024
BRIDGEWAY FUNDS INC0.03%65,900-24,000-26.70%Mar 28, 2024
IndexIQ ETF Trust0.02%42,188--Jan 31, 2024
ETFis Series Trust I0.02%24,960--Jan 31, 2024
MATTHEWS INTERNATIONAL FUNDS0.02%253,300--Mar 31, 2024
VANGUARD EXPLORER FUND0.01%171,519--Jan 31, 2024
AB CAP FUND, INC.0.01%304,171--Jan 31, 2024
LORD ABBETT SECURITIES TRUST0.01%28,444--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%336,900--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%2,890--Mar 31, 2024
Bernstein Fund Inc0.00%41,862--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.00%24,379--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%10,545--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%81,448--Mar 31, 2024
AB VARIABLE PRODUCTS SERIES FUND, INC.0.00%9,851--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%470--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%815,805-118,278-12.66%Mar 31, 2024
Legg Mason ETF Investment Trust0.00%2,884--Mar 31, 2024
LORD ABBETT SERIES FUND INC0.00%92,446--Mar 31, 2024
LORD ABBETT BOND DEBENTURE FUND INC0.00%1,315,630--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%26,211--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%162,749-694-0.42%Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%2,407--Mar 31, 2024
AMG FUNDS III0.00%3,007--Mar 28, 2024
Principal Exchange-Traded Funds0.00%6,123--Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%24,501--Mar 31, 2024
Calvert Variable Products, Inc.0.00%1,210--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%8,883--Mar 31, 2024
Fidelity Commonwealth Trust II0.00%2,191--Aug 31, 2023
FIDELITY COVINGTON TRUST0.00%5,860--Jan 31, 2024
SunAmerica Specialty Series0.00%136--Apr 30, 2021
JOHN HANCOCK INVESTMENT TRUST0.00%21,899--Mar 31, 2024
LORD ABBETT INVESTMENT TRUST0.00%247,487--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%10,000--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%30,600--Jan 31, 2024
PUTNAM VARIABLE TRUST0.00%8,252--Mar 31, 2024
NEW COVENANT FUNDS0.00%952--Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%15,758--Jan 31, 2024
HC CAPITAL TRUST0.00%4,080--Mar 31, 2024
PUTNAM FUNDS TRUST0.00%25,900--Jan 31, 2024
RBB FUND, INC.0.00%11,087--Feb 29, 2024
GPS Funds I0.00%607--Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%3,523--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%56,841--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%255--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%12,389--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%6,872--Mar 31, 2024
BERNSTEIN SANFORD C FUND INC0.00%22,182--Mar 31, 2024
BARON SELECT FUNDS0.00%763--Mar 31, 2024
NORTHERN FUNDS0.00%9,412--Mar 28, 2024
VICTORY PORTFOLIOS0.00%2,025--Mar 31, 2024
OLD WESTBURY FUNDS INC0.00%8,370--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%738--Mar 31, 2024
THRIVENT SERIES FUND INC0.00%5,702--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%3,000--Mar 31, 2024
PGIM ETF TRUST0.00%2,883--Feb 29, 2024
Fidelity Rutland Square Trust II0.00%51,550--Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS0.00%200--Mar 31, 2024
PACE SELECT ADVISORS TRUST0.00%11,871--Jan 31, 2024
ALLSPRING MASTER TRUST0.00%2,292--Feb 29, 2024
ProFunds0.00%358--Mar 31, 2024
ETF Series Solutions0.00%630--Jan 31, 2024
VALIC Co I0.00%7,822--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%52,348--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%26,560--Mar 31, 2024
BLACKROCK FUNDS0.00%169,789128,807314.30%Feb 29, 2024
FIDELITY SALEM STREET TRUST0.00%85,939--Mar 31, 2024
Franklin Alternative Strategies Funds0.00%10,675--Feb 29, 2024
PENN SERIES FUNDS INC0.00%500--Mar 28, 2024
TIAA-CREF FUNDS0.00%39,259--Mar 31, 2024
Pacer Funds Trust0.00%527--Jan 31, 2024
Goldman Sachs ETF Trust0.00%1,111--Feb 29, 2024
Brighthouse Funds Trust II0.00%9,984--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%960--Feb 29, 2024
PROSHARES TRUST0.00%2,334--Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%2,142--Jan 31, 2024
PACIFIC FUNDS SERIES TRUST0.00%2,279--Mar 31, 2023
Blackstone Alternative Investment Funds0.00%800--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%145--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%5,954--Jan 31, 2024
Meeder Funds0.00%26--Mar 31, 2024
VANGUARD WELLINGTON FUND0.00%1,735--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%12,384--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%1,277--Mar 31, 2024
iShares U.S. ETF Trust0.00%372--Jan 31, 2024
EQ ADVISORS TRUST0.00%3,775--Mar 31, 2024
iSHARES TRUST0.00%49,948-1,316-2.57%Mar 31, 2024
PACIFIC SELECT FUND0.00%9,055--Mar 31, 2024
Legg Mason Global Asset Management Trust0.00%18,311--Jan 31, 2024

NextCure's largest mutual fund holder by % of total assets is "Voya VARIABLE PRODUCTS TRUST", owning 79.82K shares, compromising 0.22% of its total assets.

NextCure Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24494.26%
31 Mar, 24479.30%
31 Dec, 2343-
30 Sep, 2343-2.27%
30 Jun, 2344-2.22%
31 Mar, 2345-
31 Dec, 2245-15.09%
30 Sep, 2253-1.85%
30 Jun, 2254-8.47%
31 Mar, 2259-16.90%
31 Dec, 2171-
30 Sep, 2171-7.79%
30 Jun, 2177-19.79%
31 Mar, 219611.63%
31 Dec, 208610.26%
30 Sep, 2078-13.33%
30 Jun, 20904.65%
31 Mar, 2086-6.52%
31 Dec, 199276.92%
30 Sep, 195220.93%
30 Jun, 1943-

As of 30 Jun 24, 49 institutions are holding NextCure's shares, representing an increase of 4.26% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2416,009,479-0.83%
31 Mar, 2416,144,04721.00%
31 Dec, 2313,341,9363.46%
30 Sep, 2312,895,577-3.18%
30 Jun, 2313,318,8750.40%
31 Mar, 2313,265,277-0.93%
31 Dec, 2213,389,532-12.16%
30 Sep, 2215,243,7085.44%
30 Jun, 2214,457,2509.24%
31 Mar, 2213,234,076-7.89%
31 Dec, 2114,367,284-2.65%
30 Sep, 2114,757,825-4.56%
30 Jun, 2115,462,322-13.91%
31 Mar, 2117,959,69223.47%
31 Dec, 2014,545,958-20.36%
30 Sep, 2018,265,401-9.78%
30 Jun, 2020,244,6370.20%
31 Mar, 2020,204,3410.06%
31 Dec, 1920,192,78578.87%
30 Sep, 1911,289,0044.71%
30 Jun, 1910,781,219-

NextCure (NXTC) has 16.01M shares outstanding as of 30 Jun 24, down -0.83% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2457.38%1.71%
31 Mar, 2458.00%2.53%
31 Dec, 2347.92%2.23%
30 Sep, 2346.34%2.02%
30 Jun, 2347.95%2.10%
31 Mar, 2347.76%2.05%
31 Dec, 2248.26%1.60%
30 Sep, 2254.93%2.02%
30 Jun, 2252.11%2.28%
31 Mar, 2247.76%1.76%
31 Dec, 2152.03%1.82%
30 Sep, 2153.44%1.70%
30 Jun, 2156.00%1.32%
31 Mar, 2165.08%2.33%
31 Dec, 2052.83%1.20%
30 Sep, 2066.30%1.23%
30 Jun, 2073.57%1.36%
31 Mar, 2073.45%0.44%
31 Dec, 19128.65%5.21%
30 Sep, 1949.70%0.78%
30 Jun, 1979.87%-

As of 30 Jun 24, NextCure is held by 57.38% institutional shareholders, representing a 1.71% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241918.75%
31 Mar, 241614.29%
31 Dec, 231440.00%
30 Sep, 2310-9.09%
30 Jun, 2311-8.33%
31 Mar, 2312-20.00%
31 Dec, 2215-11.76%
30 Sep, 2217-19.05%
30 Jun, 2221-12.50%
31 Mar, 2224-29.41%
31 Dec, 213436.00%
30 Sep, 2125-28.57%
30 Jun, 2135-22.22%
31 Mar, 21452.27%
31 Dec, 204415.79%
30 Sep, 2038-39.68%
30 Jun, 206353.66%
31 Mar, 2041-42.25%
31 Dec, 1971136.67%
30 Sep, 1930-30.23%
30 Jun, 1943-

19 institutional shareholders have increased their position in NXTC stock as of 30 Jun 24 compared to 16 in the previous quarter (a 18.75% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 249-18.18%
31 Mar, 241122.22%
31 Dec, 239-35.71%
30 Sep, 231440.00%
30 Jun, 2310-28.57%
31 Mar, 2314-12.50%
31 Dec, 2216-
30 Sep, 221614.29%
30 Jun, 2214-12.50%
31 Mar, 2216-27.27%
31 Dec, 2122-26.67%
30 Sep, 2130-3.23%
30 Jun, 2131-8.82%
31 Mar, 213421.43%
31 Dec, 202816.67%
30 Sep, 202460.00%
30 Jun, 2015-42.31%
31 Mar, 2026116.67%
31 Dec, 1912-14.29%
30 Sep, 1914-
30 Jun, 19--

9 institutional shareholders have reduced their position in NXTC stock as of 30 Jun 24 compared to 11 in the previous quarter (a -18.18% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24494.26%16,009,479-0.83%57.38%1.71%1918.75%9-18.18%
31 Mar, 24479.30%16,144,04721.00%58.00%2.53%1614.29%1122.22%
31 Dec, 2343-13,341,9363.46%47.92%2.23%1440.00%9-35.71%
30 Sep, 2343-2.27%12,895,577-3.18%46.34%2.02%10-9.09%1440.00%
30 Jun, 2344-2.22%13,318,8750.40%47.95%2.10%11-8.33%10-28.57%
31 Mar, 2345-13,265,277-0.93%47.76%2.05%12-20.00%14-12.50%
31 Dec, 2245-15.09%13,389,532-12.16%48.26%1.60%15-11.76%16-
30 Sep, 2253-1.85%15,243,7085.44%54.93%2.02%17-19.05%1614.29%
30 Jun, 2254-8.47%14,457,2509.24%52.11%2.28%21-12.50%14-12.50%
31 Mar, 2259-16.90%13,234,076-7.89%47.76%1.76%24-29.41%16-27.27%
31 Dec, 2171-14,367,284-2.65%52.03%1.82%3436.00%22-26.67%
30 Sep, 2171-7.79%14,757,825-4.56%53.44%1.70%25-28.57%30-3.23%
30 Jun, 2177-19.79%15,462,322-13.91%56.00%1.32%35-22.22%31-8.82%
31 Mar, 219611.63%17,959,69223.47%65.08%2.33%452.27%3421.43%
31 Dec, 208610.26%14,545,958-20.36%52.83%1.20%4415.79%2816.67%
30 Sep, 2078-13.33%18,265,401-9.78%66.30%1.23%38-39.68%2460.00%
30 Jun, 20904.65%20,244,6370.20%73.57%1.36%6353.66%15-42.31%
31 Mar, 2086-6.52%20,204,3410.06%73.45%0.44%41-42.25%26116.67%
31 Dec, 199276.92%20,192,78578.87%128.65%5.21%71136.67%12-14.29%
30 Sep, 195220.93%11,289,0044.71%49.70%0.78%30-30.23%14-
30 Jun, 1943-10,781,219-79.87%-43---

NextCure Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 21, 2024Webster Stephen Wdirector-A-AwardBuy18,700$1.50$28.05K18,700
Jun 21, 2024KABAKOFF DAVID Sdirector-A-AwardBuy28,050$1.50$42.08K28,050
Jun 21, 2024Jones Elaine Vdirector-A-AwardBuy18,700$1.50$28.05K18,700
Jun 21, 2024Houston John Gdirector-A-AwardBuy18,700$1.50$28.05K18,700
Jun 21, 2024Feigal Ellendirector-A-AwardBuy18,700$1.50$28.05K18,700
Jun 21, 2024Borgman Anne Elizabethdirector-A-AwardBuy18,700$1.50$28.05K18,700
Apr 02, 2024Shaw Kevin G.officer Sr VP, General CounselA-AwardBuy93,900$2.23$209.40K93,900
Apr 02, 2024Richman Michaeldirector, officer President & CEOA-AwardBuy244,400$2.23$545.01K244,400
Apr 02, 2024Myint Hanofficer Chief Medical OfficerA-AwardBuy93,900$2.23$209.40K93,900
Apr 02, 2024Mayer Timothyofficer Chief Operating OfficerA-AwardBuy93,900$2.23$209.40K93,900
Apr 02, 2024Langermann Solofficer Chief Scientific OfficerA-AwardBuy93,900$2.23$209.40K93,900
Apr 02, 2024Kundu Souravofficer Sr VP, Dev. & Mfg.A-AwardBuy52,900$2.23$117.97K52,900
Apr 02, 2024Cobourn Steven P.officer Chief Financial OfficerA-AwardBuy93,900$2.23$209.40K93,900
Feb 01, 2024Shaw Kevin G.officer Sr VP, General CounselA-AwardBuy66,125$1.22$80.67K66,125
Feb 01, 2024Richman Michaeldirector, officer President & CEOA-AwardBuy305,500$1.22$372.71K305,500
Feb 01, 2024Myint Hanofficer Chief Medical OfficerA-AwardBuy117,375$1.22$143.20K117,375
Feb 01, 2024Mayer Timothyofficer Chief Operating OfficerA-AwardBuy117,375$1.22$143.20K117,375
Feb 01, 2024Langermann Solofficer Chief Scientific OfficerA-AwardBuy117,375$1.22$143.20K117,375
Feb 01, 2024Kundu Souravofficer Sr VP, Dev. & Mfg.A-AwardBuy66,125$1.22$80.67K66,125
Feb 01, 2024Cobourn Steven P.officer Chief Financial OfficerA-AwardBuy117,375$1.22$143.20K117,375

NextCure Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20246--
Q1 202414--
Q2 20238--
Q1 20237--
Q2 202213--
Q1 20227--
Q4 20214--
Q3 20211--
Q2 20217--
Q1 20216--
Q3 202051500.00%
Q2 20209--
Q1 20207--
Q4 201932150.00%
Q2 2019366258.06%

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by NextCure's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q2 2023---
Q1 2023---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q3 2020---
Q2 2020---
Q1 2020---
Q4 20191--
Q2 20196--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of NextCure's stocks.

NextCure Peer Ownership


TickerCompany
NUVBNuvation Bio Inc.
ACHLAchilles Therapeutics plc
CTMXCytomX Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
ASMBAssembly Biosciences, Inc.
NLTXNeurogene Inc.
TILInstil Bio, Inc.

NXTC Ownership FAQ


NextCure is owned by institutional shareholders (57.38%), insiders (8.85%), and public (33.77%). The largest institutional shareholder of NextCure is SOFINNOVA INVESTMENTS, INC. (9.58% of total shares) and the top mutual fund owner is Voya VARIABLE PRODUCTS TRUST (0.22% of total shares).

NextCure's major institutional shareholders are SOFINNOVA INVESTMENTS, INC., LOGOS GLOBAL MANAGEMENT LP, AFFINITY ASSET ADVISORS, LLC, ORBIMED ADVISORS LLC, and VANGUARD GROUP INC. The top five shareholders own together 32.21% of the company's share outstanding.

As of Jun 2024, there are 49 institutional shareholders of NextCure.

SOFINNOVA INVESTMENTS, INC owns 2.67M shares of NextCure, representing 9.58% of the company's total shares outstanding, valued at $4.25M (as of Jun 2024).

As of Jun 2024, LOGOS GLOBAL MANAGEMENT LP holds 2.5M shares of NextCure (NXTC), compromising 8.96% of the company, valued at $3.98M.

AFFINITY ASSET ADVISORS, LLC is the third largest holder of NextCure. The company owns 1.69M of the company's shares outstanding (worth $2.68M).